Lyell Immunopharma plans to close its West Hills manufacturing facility by March 31, 2025, reducing its workforce by about 73 employees, and expects to incur costs of $3.0 million to $4.0 million related to this closure. Additionally, the company anticipates a net cash use of $175 million to $185 million in 2025, which should support operations into 2027.